Revolution Medicines (RVMD) Free Cash Flow (2019 - 2026)
Revolution Medicines' quarterly Free Cash Flow came in at -$355.0 million in Q1 2026, down 79.98% year-on-year from -$1.8 billion in Q1 2025, and down 29.22% quarter-over-quarter from -$274.7 million in Q4 2025.
Revolution Medicines has reported Free Cash Flow for 8 years, with the latest figure at -$355.0 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 79.98% year-over-year to -$355.0 million; the trailing twelve-month figure through Mar 2026 stood at -$1.1 billion (down 75.49% YoY), and the FY2025 full-year result was -$899.6 million, down 58.45% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$355.0 million, down from -$274.7 million in the prior quarter.
- The five-year high for Free Cash Flow was -$55.3 million in Q4 2022, with the low at -$355.0 million in Q1 2026.
- Average Free Cash Flow over 5 years is -$141.3 million, with a median of -$131.8 million recorded in 2024.
- Year-over-year, Free Cash Flow retreated 12.87% in 2023 and slumped 153.24% in 2024.
- Tracing RVMD's Free Cash Flow over 5 years: stood at -$55.3 million in 2022, then plunged by 120.47% to -$121.8 million in 2023, then slipped by 14.5% to -$139.5 million in 2024, then plunged by 96.89% to -$274.7 million in 2025, then decreased by 29.22% to -$355.0 million in 2026.
- The last three Free Cash Flow figures came in at -$355.0 million (Q1 2026), -$274.7 million (Q4 2025), and -$198.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -354.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -354.95 Mn |
| Mar 31, 2026 | -354.95 Mn |
| Dec 31, 2025 | -274.69 Mn |
| Dec 31, 2025 | -274.69 Mn |
| Sep 30, 2025 | -198.02 Mn |
| Sep 30, 2025 | -198.02 Mn |
| Jun 30, 2025 | -229.69 Mn |
| Jun 30, 2025 | -229.69 Mn |
| Mar 31, 2025 | -197.22 Mn |
| Mar 31, 2025 | -197.22 Mn |
| Dec 31, 2024 | -139.51 Mn |
| Dec 31, 2024 | -139.51 Mn |
| Sep 30, 2024 | -133.94 Mn |
| Sep 30, 2024 | -133.94 Mn |
| Jun 30, 2024 | -131.84 Mn |
| Jun 30, 2024 | -131.84 Mn |
| Mar 31, 2024 | -162.45 Mn |
| Mar 31, 2024 | -162.45 Mn |
| Dec 31, 2023 | -121.85 Mn |
| Dec 31, 2023 | -121.85 Mn |
| Sep 30, 2023 | -98.95 Mn |
| Sep 30, 2023 | -98.95 Mn |
| Jun 30, 2023 | -68.24 Mn |
| Jun 30, 2023 | -68.24 Mn |
| Mar 31, 2023 | -64.15 Mn |
| Mar 31, 2023 | -64.15 Mn |
| Dec 31, 2022 | -55.27 Mn |
| Dec 31, 2022 | -55.27 Mn |
| Sep 30, 2022 | -56.75 Mn |
| Sep 30, 2022 | -56.75 Mn |
| Jun 30, 2022 | -56.97 Mn |
| Jun 30, 2022 | -56.97 Mn |
| Mar 31, 2022 | -56.83 Mn |
| Mar 31, 2022 | -56.83 Mn |
| Dec 31, 2021 | -45.75 Mn |
| Dec 31, 2021 | -45.75 Mn |
| Sep 30, 2021 | -36.39 Mn |
| Sep 30, 2021 | -36.39 Mn |
| Jun 30, 2021 | -33.44 Mn |
| Jun 30, 2021 | -33.44 Mn |
| Mar 31, 2021 | -38.13 Mn |
| Mar 31, 2021 | -38.13 Mn |
| Dec 31, 2020 | -26.41 Mn |
| Dec 31, 2020 | -26.41 Mn |
| Sep 30, 2020 | -26.93 Mn |
| Sep 30, 2020 | -26.93 Mn |
| Jun 30, 2020 | -19.92 Mn |
| Jun 30, 2020 | -19.92 Mn |
| Mar 31, 2020 | -28.62 Mn |
| Mar 31, 2020 | -28.62 Mn |
| Dec 31, 2019 | -11.78 Mn |
| Dec 31, 2019 | -11.78 Mn |
| Sep 30, 2019 | -13.20 Mn |
| Sep 30, 2019 | -13.20 Mn |
| Jun 30, 2019 | -12.07 Mn |
| Jun 30, 2019 | -12.07 Mn |
| Mar 31, 2019 | -12.95 Mn |
| Mar 31, 2019 | -12.95 Mn |